NCT05664152View on ClinicalTrials.gov

An Open-label, Bridging Study of BARYCELA Inj. in Healthy Vietnamese Children Aged Between 12 Months to 12 Years

NAUnknownINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

February 28, 2023

Primary Completion Date

April 30, 2023

Study Completion Date

June 30, 2023

Conditions
Varicella Zoster Virus Infection
Interventions
BIOLOGICAL

MG1111

BARYCELA inj.

Sponsors

Lead Sponsor

GC Biopharma Corp
All Listed Sponsors
lead

GC Biopharma Corp

INDUSTRY